Vaccination
Flexible Use of COVID-19 Vaccines Generates Robust Immune Responses
Researchers from the University of Oxford have discovered that first doses of the Oxford/AstraZeneca and Pfizer/BioNTech vaccines, followed by second doses of the Moderna and Novavax jabs, generate robust immune responses against COVID-19. This finding supports the flexible use of these vaccines in primary immunization schedules, which is